Cytochrome P450 Oxidoreductase Gene Mutations and Antley-Bixler Syndrome with Abnormal Genitalia and/or Impaired Steroidogenesis: Molecular and Clinical Studies in 10 Patients
The DOI matches its Crossref record; 47 of the 50 references it cites were found in a registry or an index.
Abstract
We report on molecular and clinical findings in 10 Japanese patients (four males and six females) from eight families (two pairs of siblings and six isolated cases) with Antley-Bixler syndrome accompanied by abnormal genitalia and/or impaired steroidogenesis. Direct sequencing was performed for all the 15 exons of cytochrome P450 oxidoreductase gene (POR), showing two missense mutations (R457H and Y578C), a 24-bp deletion mutation resulting in loss of nine amino acids and creation of one amino acid (L612_W620delinsR), a single bp insertion mutation leading to frameshift (I444fsX449), and a silent mutation (G5G). R457H has previously been shown to be a pathologic mutation, and computerized modeling analyses indicated that the 15A>G for G5G could disturb an exonic splicing enhancer motif, and the remaining three mutations should affect protein conformations. Six patients were compound heterozygotes, and three patients were R457H homozygotes; no mutation was identified on one allele of the remaining one patient. Clinical findings included various degrees of skeletal features, such as brachycephaly, radiohumeral synostosis, and digital joint contractures in patients of both sexes, normal-to-poor masculinization during fetal and pubertal periods in male patients, virilization during fetal life and poor pubertal development without worsening of virilization in female patients, and relatively large height gain and delayed bone age from the pubertal period in patients of both sexes, together with maternal virilization during pregnancy. Blood cholesterol was grossly normal, and endocrine studies revealed defective CYP17A1 and CYP21A2 activities. The results suggest that Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis is caused by POR mutations, and that clinical features are variable and primarily explained by impaired activities of POR-dependent CYP51A1, CYP17A1, CYP21A2, and CYP19A1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When ABS is seen in association with abnormal steroids and ambiguous genitalia in either sex, the cause is an autosomal recessive mutation in POR (305, 314 -317);”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [317]
In the citing paper
“Despite its embryonic lethality in mice, POR deficiency is a newly recognized form of CAH (305, 314 -319).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [317]
In the citing paper
“This is the usual outcome among infants carrying the R457H mutation (prevalent in Japan), but not with the A287P mutation (prevalent in Europe)”
From Steroidogenic electron-transfer factors and their diseases (2021) · cites this paper as [66]
In the citing paper
“Most patients with POR deficiency have normal electrolytes and normal basal cortisol concentrations that respond poorly to ACTH, indicating compensated adrenal insufficiency”
From Steroidogenic electron-transfer factors and their diseases (2021) · cites this paper as [66]
Citations
Cites
Williams Textbook of Endocrinology
(2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,711
Listening to silence and understanding nonsense: exonic mutations that affect splicing
Cartegni, L., Chew, S. L., & Krainer, A. R. (2002) · Nature Reviews Genetics · doi:10.1038/nrg775 · Cited by 2,209 · cited 2×
“Indeed, it has been shown that silent, as well as nonsense and missense, mutations can affect the splicing mechanism (16).”
BackgroundESEfinder: a web resource to identify exonic splicing enhancers
Cartegni, L. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg616 · Cited by 1,603
Napoli, C., D'Armiento, F. P., Mancini, F. P., Postiglione, A., Witztum, J. L., Palumbo, G., & Palinski, W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119813 · Cited by 1,014 · cited 1×
“Because fetal blood cholesterol value correlates with maternal blood cholesterol value (37), a relatively large amount of cholesterol might have been transported into the developing skeletal tissues via LDL receptor with a low normal activity, as well as via other pathways (34), mitigating the skeletal features of cas…”
BackgroundMurray, R. K. (1998) · Medical Entomology and Zoology · Cited by 905
Wang, M., Roberts, D. L., Paschke, R., Shea, T. M., Masters, B. S. S., & Kim, J.-J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8411 · Cited by 744 · cited 1×
“Because the R457 residue plays an essential role in the FAD binding and stabilization (10, 14), R457H may specifically disturb the interaction with FAD in the absence of a gross conformational alteration.”
BackgroundESyPred3D: Prediction of proteins 3D structures
Lambert, C., Léonard, N., De Bolle, X., & Depiereux, E. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.9.1250 · Cited by 611
Steroidogenic enzymes: Structure, function, and role in regulation of steroid hormone biosynthesis
Hanukoglu, I. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90307-5 · Cited by 554 · cited 2×
“In addition, because CYP19A1 (aromatase) activity should also be impaired in POR mutations (9), this would affect pubertal estrogen production.”
BackgroundMutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509
Disorders of sex differentiation
Grumbach, M. M. (1992) · Medical Entomology and Zoology · Cited by 402
Cited by
Items 101–160 of 160
Tomková, M., Marohnic, C. C., Gurwitz, D., Šeda, O., Masters, B. S. S., & Martásek, P. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.21 · Cited by 17
Cytochrome P450 oxidoreductase deficiency with Antley-Bixler syndrome: Steroidogenic capacities
Iijima, S., Ohishi, A., & Ohzeki, T. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.5.469 · Cited by 16
Gusmano, C., Cannarella, R., Crafa, A., Barbagallo, F., Vignera, S. L., Condorelli, R. A., & Calogero, A. E. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01849-9 · Cited by 21
Wei, Y., Zhou, X., Fang, C., Li, L., Kluetzman, K., Yang, W., Zhang, Q.-Y., & Ding, X. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167411 · Cited by 17
“…for P450 oxidoreductase), and many mutant POR alleles have been found to be associated with congenital deficiencies in steroidogenesis/homeostasis and/or with Antley Bixler syndrome, characterized by skeletal malformation and reproductive defects (e.g., Flück et al., 2004; Fukami et al., 2005).”
BackgroundThe Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 37
Ovarian and Adrenal Androgen Biosynthesis and Metabolism
Miller, W. L., Geller, D. H., & Rosen, M. P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_2 · Cited by 19
Koyama, Y., Homma, K., Fukami, M., Miwa, M., Ikeda, K., Ogata, T., Murata, M., & Hasegawa, T. (2016) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.25.37 · Cited by 13
“Second, as we described in a previous study (1), our data in Japanese infants may not apply to other ethnicities because of differences in common POR mutations and their residual activities in PORD (9, 22, 23).”
MethodResultSelf-citationHao, C., Guo, J., Guo, R., Qi, Z., Li, W., & Ni, X. (2018) · Pediatric Investigation · doi:10.1002/ped4.12035 · Cited by 13
“4% of unrelated alleles.(9) Other ethnic groups also have the R457H mutation.”
BackgroundBiochemical analysis of mutations in P450 oxidoreductase
Pandey, A. V. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341186 · Cited by 14
Unal, E., Demiral, M., Yıldırım, R., Taş, F. F., Ceylaner, S., & Özbek, M. N. (2021) · Hormones · doi:10.1007/s42000-020-00249-z · Cited by 12
Polusani, S. R., Kar, R., Riquelme, M. A., Masters, B. S. S., & Panda, S. P. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.132 · Cited by 14
“Severe forms of CYPOR polymorphisms in humans lead to bone deformities, such as craniosynostoses, midface hypoplasia, long bone fractures, and femoral bowing, similar to the genetic disorder Antley-Bixler syndrome (ABS), along with abnormal genitalia and impaired steroidogenesis[11,12,13,14].”
BackgroundDelayed diagnosis of disorder of sex development (DSD) due to P450 oxidoreductase (POR) deficiency
Koika, V., Armeni, A. K., & Georgopoulos, N. A. (2016) · HORMONES · doi:10.14310/horm.2002.1679 · Cited by 14
Wang, C., & Tian, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1226387 · Cited by 11
Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
Zhang, J., Woo, K. L., Hai, Y., Wang, S., Lin, Y., Huang, Y., Peng, X., Wu, H., Zhang, S., Yan, L., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1020880 · Cited by 10
Inaoka, Y., Yazawa, T., Mizutani, T., Kokame, K., Kangawa, K., Uesaka, M., Umezawa, A., & Miyamoto, K. (2008) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-6-62 · Cited by 10
P450 Oxidoreductase Deficiency (PORD)
Flück, C. E., & Pandey, A. V. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00010-7 · Cited by 11
Linder, N., Mandola, A. B., Hernandez, A., Tamiri, T., Sirota, L., Klinger, G., Levy, I., & Merlob, P. (2009) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20644 · Cited by 9
Use of the Term “Antley-Bixler Syndrome”: Minimizing Confusion
Cragun, D. L., & Hopkin, R. J. (2005) · The American Journal of Human Genetics · doi:10.1086/432164 · Cited by 8
Human P450 Oxidoreductase Deficiency
Flück, C. E., & Pandey, A. V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64966-8 · Cited by 12
In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase
Nurhafizuddin, M., Azizi, A., Ming, L. C., & Shafqat, N. (2022) · Molecules · doi:10.3390/molecules27144646 · Cited by 8
“4 2/2 7/8 a 2 2 3 [3] 3 2/1 6/6 1 2 3 [15] 2 1/1 4/4 2 1 2 [16] 1 0/1 2/2 1 0 1 [17] 19 (32 b) 6 c/10 c 34/38 a 19 (32) 12 c 10 c [18] 10 6/4 19/20 a 9 9 10 [19] 3 2/1 6/6 0 2 3 [20] 7 2/5 14/14 5 2 7 [21] 1 1/0 2/2 1 1 1 [22] 1 1/0 1/2 a,d 1 1 1 [8] 4 0/4 8/8 3 3 4 [23] 1 1/0 2/2 0 1 1 [24] 12 (35 e) 7/5 24/24 11 11…”
Antley-Bixler Syndrome: Surgical Management of Ambiguous Genitalia - A Case Report
Boia, E. S., Popoiu, M. C., Puiu, M., Stănciulescu, M. C., & David, V. L. (2013) · Medical Principles and Practice · doi:10.1159/000356857 · Cited by 7
Tan, Q., Møller, A. M. J., Qiu, C., Madsen, J. S., Shen, H., Bechmann, T., Delaissé, J., Kristensen, B. W., Deng, H., Karasik, D., et al. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01449-1 · Cited by 8
Jabs, E. W., & Lewanda, A. F. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00153-1 · Cited by 6
Song, F., Feng, S., Shen, X., Du, M., Yin, H., Liu, R., & Chen, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00976 · Cited by 9
“Since this variant is a known disease-causing mutation, the clinical presentation is also summarized as Table 1 (Adachi et al., 2004; Arlt et al., 2004; Flück et al., 2004; Fukami et al., 2005; Bai et al., 2017).”
BackgroundPharmacogenetics of posttransplant diabetes mellitus
Lancia, P., de Beaumais, T. A., & Jacqz-Aigrain, É. (2017) · The Pharmacogenomics Journal · doi:10.1038/tpj.2017.1 · Cited by 6
Reisch, N., Auchus, R. J., Shackleton, C. H. L., Hanley, N. A., & Arlt, W. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007695117 · Cited by 6
[Antley-Bixler syndrome or POR deficiency?].
Tomková, M., Marohnic, C. C., Baxová, A., & Martasek, P. (2008) · PubMed · Cited by 5
Causas raras de pseudo-hermafroditismo feminino: quando suspeitar?
de Castro, M., & Elias, L. L. K. (2005) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302005000100017 · Cited by 7
Disorders of sterol biosynthesis
Furtado, L. V., Kelley, R. I., & Opitz, J. M. (2016) · Translational Science of Rare Diseases · doi:10.3233/trd-160004 · Cited by 6
Gregg, B. E., Kociolek, L. K., Qin, K., Rosenfield, R. L., & Yu, C. (2011) · Hormone Research in Paediatrics · doi:10.1159/000329857 · Cited by 4
Homma, K., Hida, M., Ikeda, K., Yamaga, N., Murata, M., & Hasegawa, T. (2009) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.18.77 · Cited by 4
“We believe that these reference values of serum 17OHP are relevant to definitive diagnosis of 21OHD as well as other adrenal disorders in newborn infants, such as P450 oxidoreductase deficiency (8, 9).”
BackgroundSelf-citationSaito‐Hakoda, A., Kanno, J., Suzuki, D., Kawashima, S., Kamimura, M., Hirano, K., Sakai, K., Igarashi, M., Fukami, M., & Fujiwara, I. (2019) · Sexual Development · doi:10.1159/000496777 · Cited by 5
Self-citationNiwa, T., Minami, K., & Katagiri, M. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-nt-102 · Cited by 3
SATO, T. A., Ishii, T., Fukami, M., Ogata, T., & Hasegawa, T. (2022) · Congenital Anomalies · doi:10.1111/cga.12464 · Cited by 5
“Regarding androgen production capacity, male patients with PORD develop variable puberty, from delayed to spontaneous pubertal development.(1) To date, studies on spermatogenesis in PORD are scarce.”
BackgroundSelf-citationP450 oxidoreductase deficiency
Flück, C. E., Velazquez, M. N. R., & Pandey, A. V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00012-5 · Cited by 4
A Novel POR G88S Mutation Causes Severe PORD and Establishes a Critical Pharmacogenomic Risk Profile
Velazquez, M. N. R., Dacal, J. L., Jørgensen, F. S., Sanguineti, N., Sharma, K., Marino, R. M., Garrido, N. P., Vaiani, E., Ramírez, P., Scaglia, P. A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf630 · Cited by 4
Uncommon Craniosynostosis Syndromes: A Review of Thirteen Conditions
Raam, M. S., & Muenke, M. (2011) · Monographs in human genetics · doi:10.1159/000319258 · Cited by 2
Cray, J. (2009) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 3
Anaforoğlu, İ. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_5 · Cited by 1
Liao, Y., Li, A., Luo, Y., Zhu, R., Zhang, C., Ma, M., Li, Y., Sun, L., Shen, M., & Qu, L. (2025) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2025.101682 · Cited by 2
The role of steroidogenesis disorders in developing congenital clitoromegaly
Ivanov, N. V., Павловна, С. И., Radugina, L. I., Михайлович, Р. Ф., & Yusupova, S. K. (2024) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2024.494 · Cited by 1
Dean, B. W., Chrisp, G. L., Quartararo, M., Maguire, A. M., Hameed, S. S., Br, K., Munns, C. F., Torpy, D. J., Falhammar, H., & Rushworth, R. L. (2020) · Yearbook of pediatric endocrinology · doi:10.1530/ey.17.8.21 · Cited by 1
Gomes, L. G. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2009.tde-09122009-152831
Comparative transcriptomics and proteomics of fetal and adult human liver
Kurbatov, L. K., Cheglakov, I. B., Yarygin, K. N., Sukhikh, G. T., Vartanian, G., Toropygin, I. Y., & Archakov, A. I. (2008) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750808030025
NEW APPROACHES IN UNDERSTANDING DRUG METABOLISM
Hart, S. N. (2011) · KU ScholarWorks (University of Kansas)
RETRACTED ARTICLE: Fetal methotrexate syndrome and Antley–Bixler syndrome should not be confused
Richards, C., Hall, C. M., Johnson, D., & Offiah, A. C. (2018) · Pediatric Radiology · doi:10.1007/s00247-018-4125-9
Retractedrevisão Causas Raras de Pseudo-Hermafroditismo Feminino: Quando Suspeitar?
de Castro, M., & Elias, L. L. K. (2005)
Subramanian, B., Chandrasekaran, A., Kumar, R., & Kukreti, R. (2020) · SBV Journal of Basic Clinical and Applied Health Science · doi:10.5005/jp-journals-10082-02269
“Drug Metab Pharmacokinet 2007;22(4):322–326.”
Honour, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818124-9.00004-8
Shafqat, N., Amdani, S. N., & Ming, L. C. (2024) · Journal of Research in Pharmacy · doi:10.29228/jrp.718
Tan, Q., Møller, A. M. J., Qiu, C., Madsen, J. S., Shen, H., Bechmann, T., Delaissé, J., Kristensen, B. W., Deng, H., Karasik, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619378
Tan, Q., Møller, A. M. J., Qiu, C., Madsen, J. S., Shen, H., Bechmann, T., Delaissé, J., Kristensen, B. W., Deng, H., Karasik, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619381
Tan, Q., Møller, A. M. J., Qiu, C., Madsen, J. S., Shen, H., Bechmann, T., Delaissé, J., Kristensen, B. W., Deng, H., Karasik, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619387
Tan, Q., Møller, A. M. J., Qiu, C., Madsen, J. S., Shen, H., Bechmann, T., Delaissé, J., Kristensen, B. W., Deng, H., Karasik, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619375
Tan, Q., Møller, A. M. J., Qiu, C., Madsen, J. S., Shen, H., Bechmann, T., Delaissé, J., Kristensen, B. W., Deng, H., Karasik, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619384
Human P450 oxidoreductase deficiency
Pandey, A. V., Barata, I. S., & Flück, C. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00259-4
Disorders of the Adrenal Cortex in the Fetus and Neonate
Flück, C. E., du Toit, T., & Miller, W. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23940-3.00035-1
Tan, Q., Møller, A. M. J., Qiu, C., Madsen, J. S., Shen, H., Bechmann, T., Delaisse, J.-M., Kristensen, B. W., HongWen, D., Karasik, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619369
Tan, Q., Møller, A. M. J., Qiu, C., Madsen, J. S., Shen, H., Bechmann, T., Delaisse, J.-M., Kristensen, B. W., HongWen, D., Karasik, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619372
A Two-Step LC-MS/MS method to differentiate 21OHD and PORD in Screen-Positive newborns
Nakatani, H., Watanabe, K., Tsuji‐Hosokawa, A., Sutani, A., Saito, Y., Kirino, S., Yamano, H., Orimoto, R., Gau, M., Yogi, A., et al. (2026) · Endocrine · doi:10.1007/s12020-026-04573-z
Self-citation
Metadata
- Authors
- Fukami, M., Horikawa, R., Nagai, T., Tanaka, T., Naiki, Y., Sato, N., Okuyama, T., Nakai, H., Soneda, S., Tachibana, K., Matsuo, N., Sato, S., Homma, K., Nishimura, G., Hasegawa, T., & Ogata, T.
- Affiliations
- National Research Institute for Child Health and Development (JP)
- National Center For Child Health and Development (JP)
- Departments of Pediatrics (T.N.)
- Departments of Pediatrics (N.M., S.Sa., T.H.), Tokyo 160-8582
- Dokkyo University (JP)
- St. Marianna University School of Medicine (JP)
- Kanagawa Children's Medical Center (JP)
- Keio University (JP)
- Tokyo Metropolitan Kiyose Children's Hospital (JP)
- Corresponding author
- Ogata, Tsutomu
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-01-01
- Volume
- 90
- Issue
- 1
- Pages
- 414-426
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2155186140
- Semantic Scholar
- 62a7c97b70b8a9cc00b8610a881abb5daade54fe
- Cited by
- 155
- References
- 50
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 3 · 2023: 7 · 2022: 5 · 2021: 5 · 2020: 7 · 2019: 7 · 2018: 4 · 2017: 4 · 2016: 7 · 2015: 2 · 2014: 2 · 2013: 5 · 2012: 8
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- Antley-Bixler syndrome, cytochrome P450 oxidoreductase, synonymous mutations, compound heterozygosity, exonic splicing enhancers, CYP17A1, CYP21A2, CYP51A1, CYP19A1, skeletal dysplasia, masculinization, delayed bone age, Japanese patients
- MeSH terms
- Abnormalities, Multiple, Adolescent, Adult, Bone and Bones, Child, Child, Preschool, Cholesterol, Cytochrome P-450 Enzyme System, Female, Genitalia, Growth, Humans, Male, Mutation, Steroids, Syndrome, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.